The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.25
Bid: 7.00
Ask: 7.50
Change: 0.50 (7.41%)
Spread: 0.50 (7.143%)
Open: 6.75
High: 7.25
Low: 6.75
Prev. Close: 6.75
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Posting of annual report and notice of AGM

5 Jul 2023 07:00

RNS Number : 9488E
Braveheart Investment Group plc
05 July 2023
 

5 July 2023

Braveheart Investment Group plc

("Braveheart", the "Company" or the "Group")

 

Posting of annual report and accounts, notice of AGM and

proposed amendment to investment strategy

 

Braveheart Investment Group (AIM: BRH), announces that the Company's annual report and accounts for the year ended 31 March 2023, which incorporates notice of the Company's 2023 Annual General Meeting ("AGM") will be posted to shareholders today and will be available to download from the Company's website at www.braveheartgroup.co.uk.

 

The AGM will be held on 28 July 2023 at 10.30 am at the office of China Ventures Ltd, Unit 2, Common Farm, Common Lane, Mappleborough Green, Warwickshire, B80 7DP.

 

Proposed amendments to the Group's investment strategy

 

The AGM notice contains a resolution (the "Investment Strategy Resolution") to permit the Directors to replace the Company's investment strategy (the "Investment Strategy") as set out in part 1 of the Company's admission document dated 27 March 2007, which determines the permitted business and strategy of the Company.

 

The proposed new Investment Strategy is set out below:

 

The Group's strategy is to invest in early and later-stage businesses, primarily in the technology sector, but it will also consider opportunities in other sectors that are knowledge intensive, such as healthcare and professional services.

 

The Group will target investments in both unlisted and listed companies, where there is potential for significant growth. Investments are expected to be mainly in the form of equity and equity-related instruments, including convertible debt instruments in certain circumstances.

 

The Group may acquire investments directly or by way of holdings in intermediate holding or subsidiary entities. The Group might also invest in limited liability partnerships and other forms of legal entity. Where possible, the Group will seek investor protection rights, as determined by the Board.

 

The Group may offer its Ordinary Shares in exchange for shares in investee businesses in addition to a cash investment in such businesses.

 

For unlisted company investments, the Group targets companies at different stages of development, ranging from those which are just starting to trade to those which are expecting to achieve an IPO in the short term, thus providing portfolio diversification. These investments will typically involve active investment management.

 

The Group, where appropriate and deemed by the Board to be in the Group's best interests, may seek a position on the boards of unlisted investee companies. The Group where appropriate, will assist the board and management of investee companies, including helping to scale management teams, informing strategy and assisting with future financing.

 

For listed company investments, the Group targets investments where the Board considers the shares are undervalued but there are opportunities for significant growth. These investments will typically involve passive investment management, although the Board may take a more active approach if it considers there is a need to effect change.

 

Braveheart may occasionally invest in companies that are in rescue or distress situations where a value-creating opportunity has been identified. The Group does not have any maximum exposure limits but will generally take a minority stake in a business and look for investments where there is a good prospect of an exit in a two-to-five-year time period.

 

As risk reduces, the Group may increase its investment in subsequent rounds of funding and, as those businesses grow, may find itself holding a controlling interest in some trading companies. However, in such instances the Board will ensure that there is sufficient separation between the Group and the investee company so that the investee company does not become a trading company of the Group.

 

Full details of the proposed amendments to the Investment Strategy are set out in the explanatory notes to the notice of AGM. Should the Investment Strategy Resolution not be passed at the AGM, the Company will not be able to make the proposed amendments to the Investment Strategy. A further announcement will be made on conclusion of the AGM.

 

For further information:

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown, Chief Executive Officer

Viv Hallam, Executive Director

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

James Reeve / George Payne

Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Duncan Vasey / Lucy Williams

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOANKQBBNBKDCOK
Date   Source Headline
14th Apr 20117:00 amRNSParticipation in £50m Business Angel Co-Investment
18th Mar 20117:00 amRNSBanking partnership with HSBC
9th Feb 20117:00 amRNSInvestment in Real-Status Limited
4th Feb 20117:00 amRNSInvestment in Pyreos Limited
27th Jan 20117:00 amRNSFurther investment in Design LED Products Ltd
29th Dec 20107:00 amRNSInvestment in payasUgym
17th Dec 20107:00 amRNSInvestment in Chargemaster
10th Dec 20107:00 amRNSInvestment in Tayside Flow Technologies Ltd
30th Nov 20107:00 amRNSHalf Yearly Report
28th Oct 20107:00 amRNSFurther Investment in Biopta Ltd
6th Oct 20107:00 amRNSCompletion of Acquisition
16th Sep 20102:43 pmRNSResult of AGM
6th Sep 20107:00 amRNSFurther Investment in Elonics Ltd
1st Sep 20107:00 amRNSFurther Investment in Traak Systems Ltd
18th Aug 201010:00 amRNSAcquisition
12th Aug 20107:00 amRNSNotice of AGM
26th Jul 20107:00 amRNSFollow-on investment in AppShare
20th Jul 201010:08 amRNSAward of Options
16th Jul 20107:00 amRNSRealisation of Investment
5th Jul 201012:32 pmRNSIssue of Equity
5th Jul 20107:00 amRNSFinal Results
2nd Jul 20107:00 amRNSInvestment in mLED Limited
1st Jul 20107:00 amRNSNotice of Results
19th May 20107:00 amRNSFollow on investment in Conjunct Limited
3rd Mar 20107:00 amRNSInvestment in Tayside Flow Technologies
18th Jan 20107:00 amRNSLaunch of Beta EIS Fund
7th Dec 20097:00 amRNSInterim Results
2nd Dec 20098:54 amRNSSubsidiary Reorganisation
27th Nov 20097:00 amRNSInvesting Policy
28th Sep 20097:00 amRNSEnterprise Finance Guarantee Scheme
25th Sep 20097:00 amRNSFollow on Investment in Appshare
9th Sep 20092:28 pmRNSResult of AGM
10th Aug 20099:14 amRNSNotice of AGM and posting of Annual Report
3rd Jul 20097:00 amRNSAward of Options
1st Jul 20097:00 amRNSFollow-on Investment in NXVision
29th Jun 20097:00 amRNSFollow-on investment in Pyreos
24th Jun 20097:00 amRNSFirst investment for Strathclyde Innovation Fund
18th Jun 20097:00 amRNSFinal Results
16th Jun 20097:00 amRNSNotice of Results
8th Jun 20097:06 amRNSAcquisition
12th May 20097:00 amRNSFollow-on Investment
19th Mar 20097:00 amRNSFollow on Investment in Traak Systems
23rd Feb 20097:00 amRNSInvestment in Pufferfish
20th Jan 20094:39 pmRNSHolding(s) in Company
6th Jan 200910:18 amRNSFollow on Investment
22nd Dec 20087:00 amRNSAward of Options
8th Dec 20087:00 amRNSHalf Yearly Report
4th Dec 20083:39 pmRNSFollow-on Investment
27th Nov 20087:00 amRNSOpening of London Office
12th Nov 20087:00 amRNSSenior Management Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.